Total Payments
$3,237
2024 Payments
$584.13
Companies
27
Transactions
210
Medicare Patients
2,337
Medicare Billing
$239,545
Payment Breakdown by Category
Food & Beverage$3,207 (99.1%)
Education$29.47 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,207 | 208 | 99.1% |
| Education | $29.47 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $807.50 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $461.36 | 31 | $0 (2024) |
| Lilly USA, LLC | $220.26 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $174.01 | 13 | $0 (2020) |
| GlaxoSmithKline, LLC. | $160.53 | 10 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $158.81 | 12 | $0 (2019) |
| Amgen Inc. | $153.49 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $136.78 | 8 | $0 (2020) |
| Astellas Pharma US Inc | $119.72 | 6 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $117.77 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $584.13 | 28 | Novo Nordisk Inc ($164.65) |
| 2023 | $371.85 | 19 | Novo Nordisk Inc ($169.15) |
| 2020 | $168.46 | 11 | Novo Nordisk Inc ($62.05) |
| 2019 | $637.06 | 51 | Novo Nordisk Inc ($209.07) |
| 2018 | $750.73 | 53 | Novo Nordisk Inc ($154.77) |
| 2017 | $724.58 | 48 | AstraZeneca Pharmaceuticals LP ($180.54) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes Care | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Biological | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: Cardiovascular | ||||||
| 06/07/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ETONOGESTREL | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Inflammation | ||||||
| 05/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: Cardiovascular | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Cardiovascular | ||||||
| 03/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Obesity | ||||||
| 02/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Diabetes | ||||||
| 02/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Bone Health | ||||||
| 01/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VACCINES | ||||||
| 01/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 541 | 826 | $164,966 | $66,156 |
| 2022 | 10 | 568 | 842 | $153,172 | $60,050 |
| 2021 | 10 | 608 | 862 | $154,774 | $61,798 |
| 2020 | 10 | 620 | 854 | $156,919 | $51,540 |
Total Patients
2,337
Total Services
3,384
Medicare Billing
$239,545
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 423 | $90,945 | $33,485 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 145 | 145 | $39,875 | $18,124 | 45.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $11,916 | $5,902 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 21 | $7,413 | $2,629 | 35.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 36 | $2,844 | $2,576 | 90.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 36 | $1,692 | $1,050 | 62.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 102 | $6,018 | $971.04 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 21 | $3,276 | $806.91 | 24.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $987.00 | $612.57 | 62.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 400 | $86,000 | $30,859 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $32,175 | $14,994 | 46.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 32 | $11,296 | $3,321 | 29.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 22 | 22 | $2,882 | $2,860 | 99.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 38 | $3,002 | $2,582 | 86.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 38 | $5,928 | $2,268 | 38.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $1,786 | $1,070 | 59.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 32 | 32 | $1,504 | $905.49 | 60.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 44 | 89 | $5,251 | $853.91 | 16.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 36 | $3,348 | $338.23 | 10.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 406 | $87,290 | $31,790 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 123 | 123 | $33,825 | $16,060 | 47.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 34 | $12,002 | $4,432 | 36.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 50 | 51 | $4,011 | $3,324 | 82.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 16 | 16 | $2,096 | $1,985 | 94.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 34 | $5,304 | $1,912 | 36.0% |
About Dr. Ragini Madan, MD
Dr. Ragini Madan, MD is a Family Medicine healthcare provider based in Apex, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528115961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ragini Madan, MD has received a total of $3,237 in payments from pharmaceutical and medical device companies, with $584.13 received in 2024. These payments were reported across 210 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,207).
As a Medicare-enrolled provider, Madan has provided services to 2,337 Medicare beneficiaries, totaling 3,384 services with total Medicare billing of $239,545. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Apex, NC
- Active Since 01/05/2007
- Last Updated 11/04/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1528115961
Products in Payments
- FARXIGA (Drug) $370.28
- Ozempic (Drug) $332.24
- Livalo (Drug) $158.81
- JARDIANCE (Drug) $137.47
- XARELTO (Drug) $121.29
- Wegovy (Drug) $117.62
- Tresiba (Drug) $100.94
- TRULICITY (Drug) $99.97
- TOUJEO (Drug) $97.54
- Rybelsus (Drug) $91.74
- Myrbetriq (Drug) $83.56
- MOUNJARO (Drug) $75.26
- Tymlos (Biological) $73.19
- JANUVIA (Drug) $68.79
- SHINGRIX (Biological) $65.74
- Victoza (Drug) $61.18
- ELIQUIS (Drug) $61.10
- BYDUREON (Drug) $57.18
- Cologuard Collection Kit (Device) $56.44
- Saxenda (Drug) $56.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Apex
Dr. Brian Forrest, M.d, M.D
Family Medicine — Payments: $331,193
Family Medicine $331,193
Teneisha Davis, M.d, M.D
Family Medicine — Payments: $20,117
Family Medicine $20,117
Dr. Craig Stevens, Md, MD
Family Medicine — Payments: $3,675
Family Medicine $3,675
Douglas Wadeson, Md, MD
Family Medicine — Payments: $2,497
Family Medicine $2,497
Mark Macpherson, D.o, D.O
Family Medicine — Payments: $2,159
Family Medicine $2,159
Dr. Maureen Dollinger, Md, MD
Family Medicine — Payments: $898.78
Family Medicine $898.78